HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer

IntroductionPredicting the response to Bacillus Calmette–Guérin (BCG) therapy in high-risk patients with non-muscle invasive bladder cancer (NMIBC) is crucial, as failure may necessitate interventions, such as radical cystectomy or salvage therapy. With the recent classification of genetic class 2a...

Full description

Bibliographic Details
Main Authors: Wook Nam, Han Kyu Chae, Yeonuk Jung, Homin Kang, Myungchan Park, Ahnryul Choi, Jong Yeon Park, Dae-Woon Eom, Sung Jin Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1301510/full